EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 41 / No 1 (March 2009) J Extra Corpor Technol, 41 1 (2009) 10-14 References
Free Access
Issue
J Extra Corpor Technol
Volume 41, Number 1, March 2009
Page(s) 10 - 14
DOI https://doi.org/10.1051/ject/200941010
Published online 15 March 2009
  1. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med. 2004;30:1873–81. [CrossRef] [PubMed] [Google Scholar]
  2. Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion. 2004;44:1453–62. [CrossRef] [PubMed] [Google Scholar]
  3. Shore-lesserson L, Gravlee GP. Anticoagulation in cardiopulmonary bypass. In: Gravlee GP, Davies R, Kurusz M, Utley JR, eds. Cardiopulmonary Bypass: Principles and Practice. Philadelphia: Lippincott Williams & Wilkins; 2000; 435–72. [Google Scholar]
  4. Ammar T, Fisher CF. The effects of heparinase 1 and protamine on platelet reactivity. Anesthesiology. 1997;86:1382–6. [CrossRef] [PubMed] [Google Scholar]
  5. Pretorius M, Scholl FG, McFarlane JA, Murphey LJ, Brown NJ. A pilot study indicating that bradykinin B-2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass. Clin Pharmacol Ther. 2005;78:477–85. [CrossRef] [Google Scholar]
  6. Miyashita T, Nakajima T, Hayashi Y, Kuro M. Hemostatic effects of low-dose protamine following cardiopulmonary bypass. Am J Hematol. 2000;64:112–5. [CrossRef] [PubMed] [Google Scholar]
  7. Shore-Lesserson L, Reich DL, DePerio M. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients. Can J Anaesth. 1998;45:10–8. [CrossRef] [PubMed] [Google Scholar]
  8. Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685–9. [CrossRef] [Google Scholar]
  9. Samolyk KA, Beckmann SR, Bissinger RC. A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: The Hemobag. Perfusion. 2005;20:343–9. [CrossRef] [PubMed] [Google Scholar]
  10. Freedman J, Luke K, Monga N, et al. A provincial program of blood conservation: The Ontario Transfusion Coordinators (ONTraC). Transfus Apheresis Sci. 2005;33:343–9. [CrossRef] [Google Scholar]
  11. Litmathe J, Boeken U, Feindt P, Gams E. Predictors of homologous blood transfusion for patients undergoing open heart surgery. Thorac Cardiovasc Surg. 2003;51:17–21. [CrossRef] [PubMed] [Google Scholar]
  12. Casati V, Guzzon D, Oppizzi M, et al. Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery. Ann Thorac Surg. 1999;68:2252–6. [CrossRef] [Google Scholar]
  13. Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg. 1995;110:36–45. [CrossRef] [Google Scholar]
  14. Koster A, Fischer T, Praus M, et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology. 2002;97:837–41. [CrossRef] [PubMed] [Google Scholar]
  15. Despotis GJ, Joist JH, Hogue CWJr, et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg. 1995;110:46–54. [CrossRef] [Google Scholar]
  16. DeLaria GA, Tyner JJ, Hayes CL, Armstrong BW. Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery. Arch Surg. 1994;129:944–50. [Google Scholar]
  17. Mejak BL, Stammers A, Rauch E, Vang S, Viessman T. A retrospective study on perfusion incidents and safety devices. Perfusion. 2000;15:51–61. [CrossRef] [PubMed] [Google Scholar]
  18. Charriere JM, Pelissie J, Verd C, et al. Survey: Retrospective survey of monitoring/safety devices and incidents of cardiopulmonary bypass for cardiac surgery in France. J Extra Corpor Technol. 2007;39:142–57. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  19. Jenkins OF, Morris R, Simpson JM. Australasian perfusion incident survey. Perfusion. 1997;12:279–88. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.